Is physician‐diagnosed allergic rhinitis a risk factor for the development of asthma?

Abstract

A diagnosis of AR was an independent risk factor for asthma in our primary care study population. Having physician-diagnosed AR increased the risk almost fivefold for a future asthma diagnosis.

Increasing prevalence of asthma, respiratory symptoms, and allergic diseases: Four repeated surveys from 1993-2014

“…During the 21 years of observation, the proportion of children with asthma who suffered from any allergic diseases increased from 53% up to 82%. This may support the idea that asthma and allergic rhinitis are different clinical manifestations of chronic inflammation of the upper and lower respiratory tracts with the same pathological mechanism where it has previously been reported that the proportion of patients with asthma who also suffer from allergic rhinitis ranges between 30 and 90% or that rhinitis may be a risk factor for asthma [26,27].…”

Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents

“…[9][10][11] In children immunotherapy has been shown to reduce the risk of new sensitizations and asthma associated with ARC. [12][13][14][15][16] In the United States immunotherapy is generally administered subcutaneously. However, concerns about serious (and possibly life-threatening) systemic reactions, as well as fear of injection, are believed to deter some patients from this treatment.…”

Toluene diisocyanate: Induction of the autotaxin-lysophosphatidic acid axis and its association with airways symptoms

“…Furthermore, the two sneezingvariables we report strengthen each other since they concern two different time spans: last three days as well as last year. Nasal symptoms, such as sneezing, should be considered as an adverse effect per se, and are of further relevance here as they often precede asthma (van den Nieuwenhof et al, 2010). In fact, nasal symptoms might be used as a critical sign for avoiding more disabling conditions such as asthma.…”